Spain vs Togo: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Spain
89.0%
in 2025
Togo
89.0%
in 2025
Spain rank
72nd
Togo rank
72nd
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Spain
- Togo
How they compare
Spain currently reports 89.0% against 89.0% in Togo, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Togo ahead.
Spain ranks 72nd and Togo ranks 72nd of 194 countries.
Across the 3 decades both report, Spain averaged higher in 1 and Togo in 1.
Head to head by decade
| Decade | Spain | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 27.8% | 43.9% | 16.1% | Togo |
| 2020s | 92.5% | 89.0% | 3.5% | Spain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Spain or Togo?
- Spain, at 89.0% against 89.0% in Togo as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Spain and Togo?
- 0.0%, with Spain ahead.
- How many years of comparable data are there for Spain and Togo?
- 18 years are reported by both, from 2008 to 2025.
- How do Spain and Togo rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Spain ranks 72nd and Togo ranks 72nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.